| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/08/2009 | US7585954 Monoclonal antibody raised by immunizing a mammal with the polypeptide CSSEVGLLKNAEREQ; binds to protein expressed in keratinocytes |
| 09/08/2009 | US7585953 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 09/08/2009 | US7585948 Soluble interleukin-20 receptor |
| 09/08/2009 | US7585947 IL-7 drug substance, composition, preparation and uses |
| 09/08/2009 | US7585946 Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions |
| 09/08/2009 | US7585942 Vascular Leak Syndrome; polypeptide toxophore from a DT; has cytotoxicity comparable to that of a DT molecule |
| 09/08/2009 | US7585938 Gamma-secretase inhibitors |
| 09/08/2009 | US7585937 GAG binding proteins |
| 09/08/2009 | US7585849 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 09/08/2009 | US7585847 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 09/08/2009 | US7585845 Using protease inhibitor |
| 09/08/2009 | US7585844 Myosin light chain kinase inhibitors and methods of use |
| 09/08/2009 | US7585843 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 09/08/2009 | US7585842 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 09/08/2009 | US7585841 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src |
| 09/08/2009 | US7585840 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 09/08/2009 | US7585839 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others |
| 09/08/2009 | US7585838 Methods of treating fibromyalgia caused by small intestinal bacterial overgrowth |
| 09/08/2009 | US7585837 derivatization of the drug with 9-fluorenylmethoxycarbonyl (Fmoc) or 2-sulfo-9-fluorenylmethoxycarbonyl (FMS) removable under mild basic conditions by attaching a protein or polymer carrier to derivatized drug molecule,such carrier serving for delivery of the drug |
| 09/08/2009 | US7585836 Bi-lateral local renal delivery for treating congestive heart failure and for BNP therapy |
| 09/08/2009 | US7585835 GASP1: a follistatin domain containing protein |
| 09/08/2009 | US7585834 Transport moiety comprises a structure; (ZYZ)nZ, (ZY)nZ, (ZYY)nZ or (ZYYY)nZ, wherein each Z is L-arginine or D-arginine, and each Y is independently an amino acid that does not comprise an amidino or guanidino moiety; n=2-10 |
| 09/08/2009 | US7585673 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 09/08/2009 | US7585671 Hedgehog interacting proteins and uses related thereto |
| 09/08/2009 | US7585666 genetically engineered chimeras comprising ligand binding domain fused to an effector domain of an apoptosis signaling molecule and second encoding a cis acting regulatory element; for use in/ex vivo |
| 09/08/2009 | US7585659 Carotene synthase gene and uses therefor |
| 09/08/2009 | US7585648 Nucleotide sequences coding myostatin epitopes for use in treatment and prevention of diabetic disorders; immunotherapy |
| 09/08/2009 | US7585647 with changed spatial configuration and improved efficacy; preventing or treating viral diseases; also an artificial gene which codes for the interferon |
| 09/08/2009 | US7585646 Human GIL-19/AE289 polynucleotides and methods of producing the encoded polypeptides |
| 09/08/2009 | US7585645 Obtaining oil bodies from a cell; washing oil bodies to obtain a washed oil body preparation; formulating washed oil bodies with thioredoxin or thioredoxin reductase into an emulsion |
| 09/08/2009 | US7585639 Methods for modulating ATP-binding cassette transmembrane reporter protein expression |
| 09/08/2009 | US7585637 Estrogen related receptor, ERRα, a regulator of bone formation |
| 09/08/2009 | US7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| 09/08/2009 | US7585618 Treatment of diabetes with milk protein hydrolysate |
| 09/08/2009 | US7585527 Comprising heme iron polypeptide and an iron material selected from ionic irons, chelated irons such as iron polysaccharide, iron bisglycinate and iron proteinate; for treating or preventing iron deficiency anemia and its symptomatic physiological, biochemical, morphological, behavioral manifestations |
| 09/08/2009 | US7585517 delivery system contains a solid core of rapamycin or other therapeutic agent |
| 09/08/2009 | US7585515 Curable mixture of a bone substitute, a dianhydride of a dicarboxylic acid and an unsaturated carboxylic acid (dimethacrylic anhydride of sebacic acid and/or 1,3-bis(p-carboxyphenoxy)propane), photoinitiator, and redox catalyst; dental, orthopedic and drug delivery applications |
| 09/08/2009 | US7585511 Apolipoprotein L-I and/or derivated polypeptide for the treatment of and/or the prevention of diseases induced by trypanosoma |
| 09/08/2009 | US7585509 Erb-2 receptor targeting peptide |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | US7585506 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/08/2009 | US7585502 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunization |
| 09/08/2009 | US7585497 Comprises nucleotide sequences coding insulin-like growth factor binding protein-3 and receptors for diagnosis, prevention and treatment of cancer; antitumor/anticarcinogenic agents |
| 09/08/2009 | US7585496 Stable pharmaceutical composition granulocyte-colony stimulating factor |
| 09/08/2009 | US7585495 Peptide-based hair conditioners and hair colorants consist of a shampoo-resistant hair-binding peptide coupled to a hair conditioning agent or a coloring agent, respectively; hair care and hair coloring product compositions |
| 09/08/2009 | CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/08/2009 | CA2440931C Hiv protease inhibitors based on amino acid derivatives |
| 09/08/2009 | CA2409546C Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 09/08/2009 | CA2361887C Method of using anti-phospholipase a2 antibodies to enhance growth or improve feed efficiency |
| 09/08/2009 | CA2360220C Oxadiazole compounds and compositions for delivering active agents |
| 09/08/2009 | CA2294701C Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/08/2009 | CA2287558C Heterocyclic derivatives and their use as antithrombotic agents |
| 09/08/2009 | CA2281955C Ikb kinase, subunits thereof, and methods of using same |
| 09/08/2009 | CA2265505C An immune disease remedy, treatment method and preventive agent and method for dogs and cats |
| 09/08/2009 | CA2261799C Composition comprising insulin and insulin-like growth factor-i (igf-i) |
| 09/08/2009 | CA2252604C Methods of treating type i hypersensitivity using monophosphoryl lipid a |
| 09/08/2009 | CA2249439C Combination of a somatostatin analogue and a rapamycin |
| 09/08/2009 | CA2224074C System and method for producing drug-loaded microparticles |
| 09/08/2009 | CA2218701C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 09/08/2009 | CA2210872C Dried composition |
| 09/04/2009 | CA2658231A1 Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo |
| 09/03/2009 | WO2009108898A2 Production and uses of type 1 ribosome inactivating proteins |
| 09/03/2009 | WO2009108868A2 Radiolabeled hedgehog derivatives for imaging and therapy |
| 09/03/2009 | WO2009108807A1 Glycopeptides and methods of making and using them |
| 09/03/2009 | WO2009108797A1 An engineered cxcl12 alpha locked dimer polypeptide |
| 09/03/2009 | WO2009108762A2 Methods and compositions for treatment of retinoid-responsive conditions |
| 09/03/2009 | WO2009108760A2 Dendritic macroporous hydrogels prepared by crystal templating |
| 09/03/2009 | WO2009108755A2 Pharmaceutical combinations for the treatment of cancer |
| 09/03/2009 | WO2009108745A1 Structure of a protein phosphatase 2a holoenzyme: insights into tau dephosphorylation |
| 09/03/2009 | WO2009108716A2 Synthetic peptides |
| 09/03/2009 | WO2009108713A2 Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides |
| 09/03/2009 | WO2009108695A2 Methods for prevention and treatment of acute renal injury |
| 09/03/2009 | WO2009108686A1 Composition comprising protein-liposome complex for iontophoresis |
| 09/03/2009 | WO2009108621A2 Methods and compositions for modulating insulin regulation |
| 09/03/2009 | WO2009108554A2 System for delivery of protein in insoluble fibrillar or aggregate form |
| 09/03/2009 | WO2009108407A1 Biodegradable therapeutic nanoparticles containing an antimicrobial agent |
| 09/03/2009 | WO2009108390A2 Method for achieving desired glial growth factor 2 plasma levels |
| 09/03/2009 | WO2009108364A2 Antagonistic analogues of ghrh |
| 09/03/2009 | WO2009108347A2 Antibacterial peptides active in systemic infections |
| 09/03/2009 | WO2009108331A2 A hybrid fusion fast fission reactor |
| 09/03/2009 | WO2009108252A2 Method for stimulating immune response against moraxella catarrhalis |
| 09/03/2009 | WO2009108153A1 Methods and compositions for the regulation of lectin complement pathway (lcp)- associated complement activation in hyperglycemic myocardial damage |
| 09/03/2009 | WO2009107766A1 Pharmaceutical composition for transnasal administration |
| 09/03/2009 | WO2009107660A1 Prophylactic or therapeutic agent for diabetes or obesity |
| 09/03/2009 | WO2009107398A1 High-molecular-weight adiponectin measurement method |
| 09/03/2009 | WO2009106986A2 Nonstructural protein ns1 as a novel therapeutic target against flaviviruses: use of inhibiting molecules interfering with ns1 maturation or biological activity |
| 09/03/2009 | WO2009106855A1 NOVEL USES OF VEGFxxxB |
| 09/03/2009 | WO2009106819A2 Biological materials and uses thereof |
| 09/03/2009 | WO2009106767A2 Use of a homeoprotein of the bicoid family for preventing or treating retinal ganglionic neurone degeneration |
| 09/03/2009 | WO2009106715A2 Peptide derived from a protein of the aquaporin family and cosmetic and/or pharmaceutical composition containing same |
| 09/03/2009 | WO2009106666A1 Recombinant antigen |
| 09/03/2009 | WO2009106624A1 Anticancer agent |
| 09/03/2009 | WO2009106532A2 Use of prokaryotic tir-domain containing proteins as therapeutic and diagnostic agents |
| 09/03/2009 | WO2009106368A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/03/2009 | WO2009106343A1 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 09/03/2009 | WO2009106339A1 A method for restoring bmp-receptor signaling in a cell |
| 09/03/2009 | WO2009106302A1 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 09/03/2009 | WO2009072802A3 Composition for slimming |
| 09/03/2009 | WO2009065561A3 System for delivery into a xcr1 positive cell and uses thereof |